Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Virtual Advanced Course on NTRK Gene Fusion: A New Target in Precision Treatment of Cancer 2021
- Start date
- 06 Dec 2021
- End date
- 07 Dec 2021
- Location
- Virtual, GMT +8
Learning objectives
- Acquire knowledge of the TRK family members and their roles in ontogenesis
- Understand the mechanisms of gene fusion and the different fusion partners involved
- Learn how TRK receptors are structured and how their activation impacts signal transduction
- Review the epidemiology of NTRK gene fusion in human tumours
- Understand the methodology to identify NTRK gene fusion and the challenges of testing
- Update knowledge on the present outcome obtained with NTRK inhibitors, their toxicities and clinical management
Accreditation
The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Tsuyoshi Saito, Japan
- Silvia Stacchiotti, Italy
- Iain Bee Huat Tan, Singapore
Supported by
